Page URL: https://www.bionews.org.uk/page_90011

Stem cell hope for genetic kidney disease

2 May 2006
By BioNews
Appeared in BioNews 356

A team of US scientists has managed to successfully treat mice with symptoms of a genetic kidney disease, using bone marrow stem cells. The researchers, based at the Beth Israel Deaconess Medical Center, transplanted stem cells into animals affected by Alport syndrome, and saw a significant improvement in their condition. It appears that the stem cells have managed to regenerate the damaged tissue and restore some of the lost kidney function, say the scientists, who published their findings in the Proceedings of the National Academy of Sciences.

Alport syndrome causes the kidneys' waste filtration system to break down. Affected individuals are born with a faulty version of one of three collagen genes, which together make the main protein component of the glomerular basement membrane (GMB). The GMB normally acts as a sieve, filtering waste products out of the blood. But in people with Alport syndrome, this membrane doesn't work properly, so blood and protein are lost in the urine, while some urea waste is retained in the body. There is currently no cure for the condition, apart from a kidney transplant or lifelong dialysis.

Previous studies have shown that stem cells derived from bone marrow have the ability to regenerate some types of damaged tissue, although it is still unclear exactly how this happens. In the latest study, the researchers decided to see if such cell transplants might help repair some of the damage caused by Alport syndrome. They gave bone marrow transplants to mice born with a type IV collagen gene mutation, using a fluorescent tag to identify the transplanted cells.

Thirteen weeks later, they found that ten per cent of the cells in the animals' kidneys were fluorescing, and that their symptoms were greatly improved. Treated mice had 70-80 per cent less protein in their urine, and 86 per cent less urea in their blood than untreated mice. 'This is encouraging, as it means that you do not need to transform a significant number of kidney cells to see an improvement', team leader Raghu Kalluri told ScienceNOW news.

The scientists say they aren't sure whether the transplanted cells are turning into new kidney cells, or whether they are simply fusing with existing unhealthy cells and passing on their genetic information. It is a key issue to resolve if the approach is ever to be used therapeutically, according to expert Richard Poulson of Cancer Research UK. This is because if the transplanted cells are exchanging genetic material with existing cells, then crucial genes could be inappropriately switched on or off, he explained.

SOURCES & REFERENCES
A World Without Dialysis?
ScienceNOW daily news |  25 April 2006
Stem Cells Might Treat Genetic Kidney Disease
Forbes.com |  28 April 2006
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
10 October 2011 - by George Frodsham 
Scientists have found a new method of suppressing the automatic rejection of donated kidneys in transplant patients, by using the donor's stem cells. In a small trial carried out at Stanford University, California, eight out of 12 patients were able to stop taking anti-rejection drugs, which are usually a lifelong necessity, following this treatment....
3 March 2006 - by BioNews 
One form of stem cell therapy for heart attack patients appears to have little effect, German researchers report. The team, based at the German Heart Centre in Munich, carried out the largest trial designed to test the therapy to date. The results, published in the Journal of the American Medical...
13 October 2005 - by BioNews 
Doctors based at Barts and the London NHS Trust have launched a trial to test if heart damage can be effectively treated using stem cells taken from a patient's own bone marrow. The study will involve 700 patients, and will look at three different types of heart damage. The trial...
26 July 2005 - by BioNews 
Doctors think they are close to treating heart attack victims with stem cells, after promising results in trials using pigs. A Phase I clinical trial on 48 patients is set to begin soon in the US to test the safety of the procedure in humans. The procedure involves injecting people...
11 February 2005 - by BioNews 
US researchers have discovered that the heart contains a type of stem cell that can divide and produce new heart cells after birth, which might allow the organ to repair itself. The surprise finding could lead to new therapies for damage caused by heart attacks. The researchers, based at the...
4 February 2005 - by BioNews 
A new type of stem cell isolated from human bone marrow could have all the medical potential of embryonic stem (ES) cells, US researchers say. However, not all scientists are convinced of that the cells are as versatile as they appear to be, according to a report in the Washington...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.